Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1993 Jan 9;306(6870):78–79. doi: 10.1136/bmj.306.6870.78

How useful is activated charcoal?

J A Vale, A T Proudfoot
PMCID: PMC1676641  PMID: 8435642

Full text

PDF
78

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boldy D. A., Smart V., Vale J. A. Multiple doses of charcoal in digoxin poisoning. Lancet. 1985 Nov 9;2(8463):1076–1077. doi: 10.1016/s0140-6736(85)90952-3. [DOI] [PubMed] [Google Scholar]
  2. Boldy D. A., Vale J. A., Prescott L. F. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. Q J Med. 1986 Nov;61(235):997–1002. [PubMed] [Google Scholar]
  3. Curtis R. A., Barone J., Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Arch Intern Med. 1984 Jan;144(1):48–52. [PubMed] [Google Scholar]
  4. Danel V., Henry J. A., Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. Br Med J (Clin Res Ed) 1988 May 28;296(6635):1507–1507. doi: 10.1136/bmj.296.6635.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elliott R. B., Crossley J. R., Berryman C. C., James A. G. Partial preservation of pancreatic beta-cell function in children with diabetes. Lancet. 1981 Jul 4;2(8236):1–4. doi: 10.1016/s0140-6736(81)90249-x. [DOI] [PubMed] [Google Scholar]
  6. Goldberg M. J., Park G. D., Spector R., Fischer L. J., Feldman R. D. Lack of effect of oral activated charcoal on imipramine clearance. Clin Pharmacol Ther. 1985 Sep;38(3):350–353. doi: 10.1038/clpt.1985.184. [DOI] [PubMed] [Google Scholar]
  7. Hillman R. J., Prescott L. F. Treatment of salicylate poisoning with repeated oral charcoal. Br Med J (Clin Res Ed) 1985 Nov 23;291(6507):1472–1472. doi: 10.1136/bmj.291.6507.1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ilett K. F., Hackett L. P., Dusci L. J., Paterson J. W. Disposition of dothiepin after overdose: effects of repeated-dose activated charcoal. Ther Drug Monit. 1991 Nov;13(6):485–489. doi: 10.1097/00007691-199111000-00003. [DOI] [PubMed] [Google Scholar]
  9. Ilkhanipour K., Yealy D. M., Krenzelok E. P. The comparative efficacy of various multiple-dose activated charcoal regimens. Am J Emerg Med. 1992 Jul;10(4):298–300. doi: 10.1016/0735-6757(92)90006-j. [DOI] [PubMed] [Google Scholar]
  10. Lalonde R. L., Deshpande R., Hamilton P. P., McLean W. M., Greenway D. C. Acceleration of digoxin clearance by activated charcoal. Clin Pharmacol Ther. 1985 Apr;37(4):367–371. doi: 10.1038/clpt.1985.55. [DOI] [PubMed] [Google Scholar]
  11. Lim D. T., Singh P., Nourtsis S., Dela Cruz R. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal. Ann Emerg Med. 1986 Nov;15(11):1303–1307. doi: 10.1016/s0196-0644(86)80615-1. [DOI] [PubMed] [Google Scholar]
  12. Mauro L. S., Mauro V. F., Brown D. L., Somani P. Enhancement of phenytoin elimination by multiple-dose activated charcoal. Ann Emerg Med. 1987 Oct;16(10):1132–1135. doi: 10.1016/s0196-0644(87)80471-7. [DOI] [PubMed] [Google Scholar]
  13. Mayer A. L., Sitar D. S., Tenenbein M. Multiple-dose charcoal and whole-bowel irrigation do not increase clearance of absorbed salicylate. Arch Intern Med. 1992 Feb;152(2):393–396. [PubMed] [Google Scholar]
  14. McNamara R. M., Aaron C. K., Gemborys M., Davidheiser S. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann Emerg Med. 1989 Sep;18(9):934–938. doi: 10.1016/s0196-0644(89)80456-1. [DOI] [PubMed] [Google Scholar]
  15. Neuvonen P. J., Elfving S. M., Elonen E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol. 1978 May 31;13(3):213–218. doi: 10.1007/BF00609985. [DOI] [PubMed] [Google Scholar]
  16. Neuvonen P. J., Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol. 1980 Jan;17(1):51–57. doi: 10.1007/BF00561677. [DOI] [PubMed] [Google Scholar]
  17. Neuvonen P. J., Elonen E., Mattila M. J. Oral activated charcoal and dapsone elimination. Clin Pharmacol Ther. 1980 Jun;27(6):823–827. doi: 10.1038/clpt.1980.117. [DOI] [PubMed] [Google Scholar]
  18. Neuvonen P. J., Olkkola K. T. Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent. J Toxicol Clin Toxicol. 1984;22(2):103–114. doi: 10.3109/15563658408992547. [DOI] [PubMed] [Google Scholar]
  19. Neuvonen P. J., Vartiainen M., Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol. 1983;24(4):557–562. doi: 10.1007/BF00609903. [DOI] [PubMed] [Google Scholar]
  20. Olkkola K. T., Neuvonen P. J. Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol. 1984 Nov;18(5):663–669. doi: 10.1111/j.1365-2125.1984.tb02527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scheinin M., Virtanen R., Iisalo E. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin. Int J Clin Pharmacol Ther Toxicol. 1985 Jan;23(1):38–42. [PubMed] [Google Scholar]
  22. Scolding N., Ward M. J., Hutchings A., Routledge P. A. Charcoal and isoniazid pharmacokinetics. Hum Toxicol. 1986 Jul;5(4):285–286. doi: 10.1177/096032718600500414. [DOI] [PubMed] [Google Scholar]
  23. Sessler C. N., Glauser F. L., Cooper K. R. Treatment of theophylline toxicity with oral activated charcoal. Chest. 1985 Mar;87(3):325–329. doi: 10.1378/chest.87.3.325. [DOI] [PubMed] [Google Scholar]
  24. Tenenbein M., Cohen S., Sitar D. S. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med. 1987 Aug;16(8):838–841. doi: 10.1016/s0196-0644(87)80518-8. [DOI] [PubMed] [Google Scholar]
  25. el-Bahie N., Allen E. M., Williams J., Routledge P. A. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. Br J Clin Pharmacol. 1985 Jun;19(6):836–838. doi: 10.1111/j.1365-2125.1985.tb02724.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES